|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Arqule, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
ArQule is a clinical-stage biotechnology company engaged in the research and development of small-molecule cancer therapeutics. The company's products and research programs are focused on key biological processes that are central to cancer.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Allos Therapeutics, Inc.
Company Financials: Genzyme Corporation
Company Financials: Biocryst Pharmaceuticals
Company Financials: Genta Incorporated
Company Financials: GTx, Inc.
Company Financials: Amgen, Inc.
Company Financials: Array Biopharma Inc.
Company Financials: ImmunoGen, Inc.
Company Financials: Mannkind Corporation
Company Financials: Exelixis
|
|
|
|
